viewAlba Mineral Resources PLC

Alba Mineral Resources finishes first ever exploratory drilling at Welsh gold mine

The company said it took “great confidence in the geological model that has been developed” from the drilling campaign, which showed quartz veining continued below previously mined areas

Alba Mineral Resources PLC -

Alba Mineral Resources PLC (LON:ALBA) has celebrated the completion of the first-ever exploration drilling campaign at the Clogau-St David's gold mine in Wales.

In an update on Friday, the developer and explorer said that drilling confirmed that shear zone-hosted quartz veining, thought to contain gold, continued at least 25m down below the historic mining area.

READ: Alba Mineral Resources looks forward to HH-2 production tests in early December

The company is targeting extensions into unworked areas in the Llechfraith mine area and said that since no mine workings or voids were intersected during the drilling, it had “great confidence in the geological model that has been developed”.

Three drill-holes were completed for a total of 158m, of which two, GMOW002 and GMOW003 reached the target depths, with GMOW001 being terminated early.

Next, the drill core is being sent to an accredited laboratory for assaying and depending on the results future work at the mine could include dewatering to enable access and allow bulk sampling to be carried out of the areas of reported visible gold. 

Otherwise, the company plans to drill in 2020 both from surface and from underground within the mine itself.

Welsh gold sells for a substantial premium to the spot price.

Shares were up 3% at 0.17p in Friday afternoon trading.

Quick facts: Alba Mineral Resources PLC

Price: 0.325 GBX

Market: AIM
Market Cap: £20.24 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bionomics' positive pharmacokinec results confirms it can begin second Phase...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

15 hours, 38 minutes ago

2 min read